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Background. Although deworming pregnant women is one of the strategies to reduce parasites (roundworms and hookworms)
causing anemia and related perinatal and maternal complications, utilization of deworming medication among pregnant women
in Cameroon is suboptimal. Comprehensive assessment of individual, household (including women’s autonomy), and
community-level factors associated with utilization of deworming medication has not been done so far. Therefore, we
investigated the individual/household and community-level factors associated with deworming among pregnant married women
in Cameroon. Methods. Our study was limited to pregnant women because they have a greater risk due to increased chances of
anemia. We used data from the 2018/19 Cameroon Demographic and Health Survey. Analysis on 5,013 pregnant married
women was carried out using multilevel logistic regression. Odds ratios with a 95% confidence interval (CI) were reported.
Results. Our findings showed that about 29.8% of pregnant married women received deworming medications. The
individual/household level predictors of deworming medications utilization identified in this study were women’s educational
level, wealth quintile, and skilled antenatal care. Distance to health facility and region were identified as community-level
predictors of deworming medications utilization. Higher odds of receiving deworming medication occurred among educated
and wealthier pregnant married women as well as among pregnant married women who had skilled antenatal care or lived in
the south region, whereas lower odds were observed among pregnant married women living in the north region. Conclusion.
Access to education and economic empowerment of pregnant married women in remote areas and the north region should be
the primary focus of the Cameroon government to enhance deworming coverage in the country.
1. Background
Soil-transmitted helminths (STH) are one of the major public
health problems as it predominantly affects people in low-
and middle-income countries [1–3]. Globally, nearly 1.3 bil-
lion people are affected by STH [1], and in 2010, STH caused
4.98 million disability-adjusted life years [2]. Evidence in 102
STH-endemic countries in 2015 [4] revealed that STH
infected more than 2 billion people who in turn lose an
estimated 39 million disability-adjusted life years [4]. The
problems of STH are highly prevalent in South East Asia
and sub-Saharan African countries, especially in the tropical
and sub-tropical parts of sub-Saharan Africa (SSA) [5]. In
Africa, about ten million pregnant women suffer from
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anemia due to schistosomiasis and about 7 million pregnant
women in SSA are infected with hookworms [6]. STH are
common diseases and distinctive among communities with
inadequate infrastructure, hygiene, or sanitation facilities
and among communities with poor awareness of the benefits
of proper face disposal [7].
There are three high-risk groups; women of reproductive
age, preschool age, and school-age children in which STH
become more severe and may even lead to death once
infected [4]. Within women of reproductive age, pregnant
women have a higher risk compared to nonpregnant women.
Due to the intensity of anemia in pregnancy, they become
more worsened if they acquire additional infestation of hel-
minths, especially by hookworms as they are less resistant
to infection [8, 9]. Anemia has several effects on pregnant
women including increased susceptibility to infection, still-
birth/miscarriage [10, 11], and poor feto-maternal outcomes
such as preterm birth, low birth weight, and infant or child
mortality [11–13]. In pregnancy, infections are the major
causes of anemia, which can be prevented by taking deworm-
ing medication, sleeping in bed net and taking intermittent
preventive malaria treatment [14]. In addition to the individ-
ual level effect, anemia has huge health and adverse economic
effects for communities and nations [14].
Communities and national health and economic adverse
effects of anemia are greatly seen; due to the societal conse-
quences of increased maternal mortality and resultant
restraints on productivity, the costs incurred by the public
and private sectors in the therapeutics measures for the prev-
alent level of anemia and the long-term projected negative
consequence of impaired mental development on the human
capital formation [15]. However, the degree of communities
and national health and economic adverse effects depend on
the number of individuals affected by anemia, severity of ane-
mia, and duration and consequence of the condition [15].
Moreover, among children, significant growth retardation
and delayed cognitive development are common and associ-
ated with Trichuris trichiura and Ascaris lumbricoides [16, 17].
As a public health intervention, WHO recommended
deworming or preventive chemotherapy (PC) for pregnant
women after first trimester, using a single dose of mebenda-
zole (500mg) or albendazole (400mg) in areas where there
is 40% or higher anemia prevalence among pregnant women
and the prevalence of T. Trichiura and hookworm are 20%
and above [18]. As documented in several prior studies, pre-
vention chemotherapy or deworming of pregnant women
and children significantly enhance hemoglobin level and
nutritional status [19–21], and as a result, their wellbeing
can be improved whilst huge reduction of morbidity and
mortality can be achieved [22]. Mothers who are dewormed
during pregnancy tend to have an improved birth weight of
their babies [23, 24]. Moreover, a reduction of the prevalence
of very low birth weight (birth weight less than 1500 grams)
is seen among women who take deworming medicine during
pregnancy [25].
Cameroon is one of the STH endemic countries with
moderate STH infestation where no substantial progress
has been observed in its reduction [26]. In Cameroon, nearly
half of pregnant women (49.3%) were anemic as of 2016 [27];
however, there is low coverage of deworming medication
[14]. For instance, according to the 2011 Cameroon Demo-
graphic and Health Survey (CDHS), less than 40% of
pregnant women received deworming medication [14]. Evi-
dence shows that individual and communities’ socioeco-
nomic status and geographic-related factors affect the
uptake of deworming medication [28]. Besides, married
women are less likely to use maternal health services includ-
ing uptake of deworming medication due to low autonomy
or participation in decision-making within the household
[29, 30] and gender inequality or male dominance [29–32].
Regarding socioeconomic factors, for instance, noneducated
pregnant women are less likely to take deworming medica-
tion due to poor awareness and utilization of maternal health
services, including antenatal care (ANC) that comprises sup-
plementation of deworming medication [33–35]. Women in
the poorest household are more likely to be challenged by the
problem of affordability of transportation to health facility
[36]. Moreover, women living in distant and rural areas
and regions with underdeveloped infrastructures such as
road are less likely to take deworming medication from a
health facility or drug stores [37].
To the best of our knowledge, a comprehensive assess-
ment of predictors of deworming medication among preg-
nant married women has not been done in Cameroon.
Hence, the purpose of this study was to determine the cover-
age and individual/household and community-level predic-
tors of utilization of deworming among married women
during pregnancy in Cameroon. The findings from this study
could help to enhance national deworming medication
coverage by intervening on current individual/household
and community level predictors, which can potentially
reduce helminthic-related anemia among pregnant married
women in the country.
2. Methods
2.1. Data Sources and Sampling Procedure. The data used for
the analysis in this study were extracted from the 2018/19
Cameroon Demographic and Health Survey (CDHS), which
is carried out by the Cameroon National Institute of Statistics
(CNIS) in collaboration with the Ministry of Health
(MOH) with financial and technical support from the
United States Agency for International Development
(USAID) and ICF International [38]. The CDHS collects
data to produce evidence for monitoring vital population
and several health indicators including utilization of
deworming medications [38].
In the CDHS, the two-stage stratified cluster sampling
technique was applied. In the first stage, primary sampling
units (PSUs) or enumeration areas (EAs) were selected from
the sampling frame, which was prepared from the recent
population census using probability proportional to size
[38]. In the second stage, a fixed number of households
[25–30] were selected from the selected EAs using a system-
atic sampling technique [38]. A total of 14,677 women aged
15-49 and 6,978 men aged 15-64 were interviewed from
11,710 households [38]. Detailed descriptions of the method-
ology used in the survey are explained in the final report of
2 BioMed Research International
the 2018/19 CDHS [38]. For this study, we used the Indi-
vidual Recode (IR) file and limited the analysis to a sam-
ple of 5,013 pregnant married women. We used IR file
because datasets for measuring women’s health indicators
such as the utilization of deworming medication are found
in that file [39]. In addition, we limited the study to mar-
ried women because female empowerment factors such as
decision-making power were confined to only married
women [39–41].
2.2. Study Variables
2.2.1. Outcome Variable. Utilization of deworming medica-
tion was the outcome variable for this study. The WHO
recommends that pregnant women take a single dose of
mebendazole (500mg) or albendazole (400mg) after the sec-
ond trimester [18]. The DHS asked pregnant women who
took deworming medication with a birth in the last five years
[18, 39, 42]. We categorized and coded responses to binary as
“yes” if they took and “no” if they did not take the deworming
medication.
2.2.2. Explanatory Variables.We incorporated several indivi-
dual/household and community level explanatory variables
based on available evidence on the uptake of deworming
medication among pregnant women [19–25, 28, 43]. We
incorporated the following individual/household level pre-
dictors and coded them as follows: maternal educational level
(no education, primary, secondary, higher), husband’s edu-
cational level (no education, primary, secondary, higher),
women’s occupation (not working, clerical, sales, agricultural
self-employed, services, skilled manual, unskilled manual),
husband’s occupation (not working, professional or technical
or managerial, clerical, sales, agricultural self-employed, ser-
vice, skilled manual, unskilled manual) religion (Catholic,
Protestant, Other Christians, Muslim, Other), sex of house-
hold head (male, female), and skilled antenatal care (ANC)
(no, yes). The wealth index was coded as poorest, poorer,
middle, richer, and richest. In DHS, for measuring house-
holds’ economic status, the wealth index is usually computed
using durable goods, household characteristics, and basic ser-
vices following the methodology explained elsewhere [44],
and we followed the same procedure. Regarding media expo-
sure (yes, no), we coded yes if the women read newspaper, lis-
tened radio, or watched television for at least less than once a
week, and no for otherwise. Women’s decision-making
power was coded as yes versus no. If the women decided,
either alone or together with their husband on all three of
decision-making parameters; their own health, to purchase
large household expenses, to visit families or relatives, the
women considered as having decision-making power. How-
ever, if the woman did not decide, either alone or together
with her husband, on at least one of the three abovemen-
tioned decision-making parameters, the woman was consid-
ered as having no decision-making power.
The community-level factors included in this study were
as follows: distance to health facility (big problem, not a big
problem) place of residence (urban, rural), and region (Ada-
mawa, Centre [without Yaoun], Douala, East, Far-North, Lit-
toral [without Dou], North, North-West, West, South,
South-West, Yaounde). Others were community literacy
level (low, medium, high) and community socioeconomic
status (low, moderate, high). In this study, a big problem
indicates that the distance from women’s home to health
facility (could it be a health center or hospital) to get medical
help for herself was problematic. If the women responded as
the distance was a big problem, we coded as 1 if the women
reported as not a big problem and coded as 0 if the women
were reported as a big problem. The socioeconomic status
variable was an aggregation from occupation, wealth, and
education of research participants who resided in a given
community. We further applied principal component analy-
sis to estimate women who were unemployed, uneducated,
and poor. A standardized score was derived with a mean
score (0) and standard deviation [1]. The scores were then
segregated into tertile 1 (least disadvantaged), tertile 2,
and tertile 3 (most disadvantaged), where the least score
(tertile 1) denoted greater socioeconomic status and the
highest score (tertile 3) denoting lower socioeconomic sta-
tus. Community literacy level was derived from women
who could read and write (or not read and write) at all.
2.3. Statistical Analyses. First, descriptive analysis including
frequency distribution of respondents, utilization of
deworming medication, and utilization across explanatory
variables was conducted. Then, a chi-square test of indepen-
dence was carried out to select variables that had a significant
association with utilization of deworming medications at P
value 0.05 cut point. Subsequently, a multicollinearity test
was done using variance inflation factor (VIF) for all statisti-
cally significant variables at the chi-square test, and we found
no evidence of high collinearity among the explanatory vari-
ables (MeanVIF = 1:71, Min VIF = 1:03, Max VIF = 3:51).
Based on available evidence, a mean VIF less than 10 is
acceptable [45, 46].
Finally, four different models were constructed using the
multilevel logistic regression (MLLR) technique to assess
whether or not the individual/household and community
level predictors had significant associations with the outcome
variable (utilization of deworming medication). The first
model was a null model, which had no explanatory variables,
and it displayed variance in the coverage of deworming med-
ication, attributed to PSU. The second model called model I
incorporated only the individual/household level predictors
and the third model (Model II) included community-level
predictors only. The final model, (Model III), comprised both
the individual/household and community level predictors.
All four MLLR models included fixed and random effects
[47–49]. The fixed effects indicated the association between
the explanatory variables and the outcome variable and the
random effects signified measure of variation in the outcome
variable based on PSU, which is measured by intracluster
correlation (ICC) [50]. Finally, the model fitness, or how
the different models were fitted with the data, was examined
using Akaike’s Information Criterion (AIC) [51]. We used
the “mlogit” command to run the MLLR models. Weighting
was done to take into account the complex nature of DHS
data, while the “svyset” command was used for adjusting
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for disproportionate sampling and nonresponse. The analy-
sis was conducted using the Stata version-14 software (Stata
Corp, College Station, Texas, USA).
2.4. Ethical Considerations. We used publicly available DHS
data from MEASURE DHS for analysis of this study. Since
the institution commissioned, funded, and managed the
survey, further ethical clearance is not required. ICF interna-
tional ensured that the protocol of the survey was compliant
with the U.S. department of health and human service regu-
lations to protect human subjects.
3. Results
3.1. Sociodemographic Characteristics of Respondents. In this
study, a total of 5,013 pregnant married women participated.
Of them, 52.5% were rural residents. Nearly 40% of the
respondents had attended secondary school, while 31.1%
and 29.6% had attended primary school and not had formal
education, respectively. More than 89% of the respondents
were followers of Catholic (34.9%), Muslim (30.3%), and
Protestant (23.9%) faiths, respectively. About 85.9% of the
married women had skilled ANC. Regarding women’s
decision-making capacity, about 47.7% of women decided
in all of the three decision-making parameters (their own
health, large household expenses, and visiting family/rela-
tive) either alone or together with their husband (Table 1).
3.2. Utilization Coverage of Deworming Drugs across
Explanatory Variables. Table 1 shows variations in the utili-
zation of deworming drugs among married women across
various subpopulations. For instance, the utilization among
pregnant married women who had attended secondary and
higher school was 41.1% and 40.2%, respectively, but it was
16.2% among pregnant married women who had no formal
education. Utilization also varied from 16.3% among married
pregnant women in the poorest subgroup to 40.6% and
42.6% among pregnant married women in the richer and
richest subgroups, respectively. Approximately 39.2% of
pregnant married women who had media exposure (newspa-
per, radio, or television) took deworming drugs, whereas
nearly 22.4% of pregnant married women who had no media
exposure took the drugs. About 54.1% of women living in the
south region took the deworming drugs; however, only 9.1%,
23.3%, and 24.8% of pregnant women in North, Adamawa,
and Far-North regions, respectively, took the deworming
drugs (Table 1).
3.3. Measure of Association (Fixed Effects) Results
3.3.1. Individual/Household Level Predictors. The study
shows that women’s educational status, economic status,
and skilled ANC were significant individual/household level
predictors for utilization of deworming drugs among preg-
nant married women in Cameroon. We found that the likeli-
hood of taking deworming drugs among pregnant married
women who had attended secondary school (aOR = :38,
95% CI; 1.04-1.83) was higher as compared to pregnant mar-
ried women who had no formal education. Moreover, the
study shows that the likelihood of taking deworming medica-
tion among pregnant married women in the richest
(aOR = 1:90, 95% CI; 1.25-2.88), richer (aOR = 1:69, 95%
CI; 1.17-2.44), and middle (aOR = 1:39, 95% CI; 1.01-1.90)
categories were higher, respectively, as compared to pregnant
married women in the poorest categories. We found higher
odds of the utilization of deworming medication among
pregnant married women who had skilled ANC
(aOR = 18:54, 95% CI; 11.05-31.10) as compared to pregnant
married women who had no skilled ANC (Table 2).
3.3.2. Community Level Predictors. This study shows higher
odds of the utilization of deworming medication among
pregnant married women who reported distance to health
facility was not a big problem (aOR = 1:19, 95% CI; 1.02-
1.39) as compared to women who reported distance to health
facility was a big problem. Significant regional variations in
the utilization of deworming medication among pregnant
married women were observed. In fact, we found higher odds
of the utilization of deworming medication among pregnant
married women living in the South region (aOR = 2:09, 95%
CI; 1.27-3.45) as compared to pregnant married women liv-
ing in the Adamawa region. However, the likelihood of tak-
ing deworming medication among pregnant married
women living in the North region was lower (aOR = 0:27,
95% CI; 0.17-0.43) as compared to pregnant married women
living in the Adamawa region (Table 2).
3.4. Measures of Variations (Random Effects) Results. The
results of the Model 0 of Table 2 show that coverage of
deworming medication varies significantly across the clusters
(σ2 = 1:45, 95% CI; 1.17-1.80). Model 0 revealed that 30% of
coverage of deworming medication was related to the
between-cluster variations (ICC = 0:30). The between-
cluster difference decreased from 30% in the Null model
(Model 0) to 23% in the model that had only the individual/-
household level variables (Model I). The between-cluster dif-
ference decreased from 23% in the Model I to 21% in the
community level only model (Model II) and again to 18%
in the complete model (Model III) that included both indivi-
dual/household and community level factors. This specifies
that the differences in the coverage of deworming medication
can be clarified by the variances across the clusters (Table 2).
4. Discussion
In this study, the individual/household and community-level
predictors of deworming medication among pregnant mar-
ried women during pregnancy were thoroughly investigated
using data from the 2018/19 CDHS. The findings show that
the utilization of deworming medication in Cameroon was
29.8%. We found women’s education, household economic
status, and skilled ANC to be the individual/household level
predictors of utilization of deworming medication, whereas
the distance to health facility and region were the community
level predictors.
More specifically, we found that the likelihood of taking
deworming medication was higher among pregnant married
women who had attended secondary school compared to
pregnant married women who had no formal education.
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No education 2,070 25.68 29.56 1,079 (83.84) 208 (16.16)
Primary school 2,721 33.76 31.1 1,102 (66.99) 543 (33.01)
Secondary school 2,868 35.58 33.99 1,075 (58.90) 750 (41.10)




No education 1,876 23.28 26.17 943 (80.32) 231 (19.68)
Primary school 2,590 32.13 31.31 1,094 (68.81) 496 (31.19)
Secondary school 2,899 35.97 33.67 1,128 (61.20) 715 (38.80)




Not working 2,153 26.71 25.54 1,011 (71.05) 412 (28.95)
Clerical 116 1.44 1.42 37 (61.67) 23 (38.33)
Sales 1,638 20.32 20.05 570 (61.69) 354 (38.31)
Agricultural self-employed 2,865 35.55 36.45 1,288 (72.00) 501 (28.00)
Services 791 9.81 9.8 279 (59.11) 193 (40.89)
Skilled manual 385 4.78 4.99 181 (64.41) 100 (35.59)




Not working 347 4.31 3.73 58 (59.18) 40 (40.82)
Professional/technical/managerial
318 3.95 3.77 183 (61.41) 115 (38.59)
Clerical 147 1.82 1.64 912 (66.09) 468 (33.91)
Sales 1,324 16.43 15.95 1,534 (74.90) 514 (25.10)
Agricultural self employed 3,229 40.06 41.1 613 (59.28) 421 (40.72)
Service 913 11.33 11.02 109 (70.32) 46 (29.68)
Skilled manual 1,512 18.76 19.18 58 (59.18) 40 (40.82)




Poorest 1,415 17.56 21.25 831 (83.69) 162 (16.31)
Poorer 1,732 21.49 20.53 810 (70.74) 335 (29.26)
Middle 1,893 23.49 19.91 747 (66.11) 383 (33.89)
Richer 1,593 19.76 19.23 577 (59.36) 395 (40.64)




Catholic 2,805 34.80 34.85 1,084 (63.88) 613 (36.12)
Protestant 2,138 26.53 23.89 820 (63.13) 479 (36.87)
Other Christians 579 7.18 6.38 254 (66.32) 129 (33.68)
Muslim 2,227 27.63 30.26 1,101 (75.77) 352 (24.23)
Other 311 3.86 4.62 150 (82.87) 31 (17.13)
Media exposure
χ2 = 154:28,
P < 0:001No 3,374 41.86 44.16 1,681 (77.36) 492 (22.64)
Yes 4,686 58.14 55.84 1,728 (60.85) 1,112 (39.15)
Decision-making
χ2 = 44:11,
P < 0:001No 3,961 49.14 52.31 1,938 (72.07) 751 (27.93)
Yes 4,099 50.86 47.69 1,471 (63.30) 853 (36.70)
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Several studies confirm that there is a significant association
between maternal educational status and maternal health
service utilization such as ANC [33, 34] and uptake of
deworming medication [28]. The possible reason for better
uptake of maternal health service among educated women
might be due to higher health knowledge among educated
women as compared to noneducated [35]. Not only that edu-
cational attainment has also been considered as an important
social determinant of maternal, newborn, and child health
[52]. Education encourages women to have autonomy, self-
confidence, and health information and make an informed
decision about their health [53, 54].
We found higher odds of taking deworming medication
among pregnant married women in higher economic status
compared to the poorest pregnant women. A previous study
in Ghana reported similar findings [28]. Having a better
socioeconomic situation as a woman facilitates not only
access or affordability of transport costs but also helpful in
buying the medication whenever the health facilities have
supply problem or not available in dispensary or drug store
[36]. Evidence shows that the early beginning of ANC service
[55] and higher uptake of ANC service are seen among preg-
nant married women in better socioeconomic status as com-
pared to women in lower economic status [33, 34, 55, 56].
The burdens of helminthic infection are prevalent among
countries and communities with low socioeconomic status
[57]. This evidence is supported by WHO’s finding that
showed the burden of maternal anemia is highly prevalent
in South-East Asia and Africa, where higher parasitic infec-














Sex of HH head
χ2 = 12:45,
P < 0:001Male 6,925 85.92 86.79 2,995 (68.91) 1,351 (31.09)
Female 1,135 14.08 13.21 414 (62.07) 253 (37.93)
Skilled ANC
χ2 = 326:97,
P < 0:001No 695 13.86 14.02
Yes 4,318 86.14 85.98
Distance to HF
χ2 = 56:49,
P < 0:001Big problem 3,211 43.03 42.41 1,622 (73.59) 582 (26.41)
Not a big problem 4,252 56.97 57.59 1,787 (63.62) 1,022 (36.38)
Place of residence
χ2 = 54:46,
P < 0:001Urban 3,774 46.82 47.46 1,394 (62.57) 834 (37.43)




Adamawa 690 8.56 5.29 330 (76.74) 100 (23.26)
Centre (without Yaoun) 826 10.25 9.53 338 (64.88) 183 (35.12)
Douala 555 6.89 10.11 176 (59.26) 121 (40.74)
East 718 8.91 6.26 301 (63.91) 170 (36.09)
Far-North 1,051 13.04 18.26 555 (75.20) 183 (24.80)
Littoral (without Dou) 495 6.14 3.45 191 (67.97) 90 (32.03)
North 1,017 12.62 15.64 621 (90.92) 62 (9.08)
North-West 383 4.75 5.75 132 (53.23) 116 (46.77)
West 788 9.78 10.68 310 (63.66) 177 (36.34)
South 778 9.65 4.69 196 (45.90) 231 (54.10)
South-West 164 2.03 1.58 49 (55.68) 39 (44.32)
Yaounde 595 7.38 8.76 210 (61.40) 132 (38.60)
Community literacy level .
χ2 = 197:26,
P < 0:001
Low 3,296 40.89 44.74 1,724 (78.12) 483 (21.88)
Medium 2,532 31.41 27.2 944 (62.89) 557 (37.11)




Low 3,973 49.29 50.03 1,942 (74.58) 662 (25.42)
Moderate 1,766 21.91 19.01 686 (63.34) 397 (36.66)
High 2,321 28.80 30.96 781 (58.90) 545 (41.10)
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Table 2: Multilevel multivariable results for individual/household and community-level predictors of utilization of deworming medication
among pregnant women: evidence from 2018/19 CDHS.
Variables Model 0 Model I AOR [95% CI] Model II AOR [95% CI] Model III AOR [95% CI]
Women’s educational status
No formal education (ref)
Primary school 1.38 (1.08-1.77)∗ 1.27 (0.99-1.64)
Secondary school 1.53 (1.16-2.02)∗∗ 1.38 (1.04-1.83)∗
Higher 1.43 (0.93-2.22) 1.28 (0.82-1.98)
Husband educational status
No formal education (ref)
Primary school 0.91 (0.72-1.15) 0.85 (0.67-1.07)
Secondary school 0.92 (0.72-1.17) 0.86 (0.67-1.09)
Higher 0.87 (0.60-1.25) 0.83 (0.58-1.19)
Women occupation
Not working (ref)
Clerical 0.92 (0.51-1.69) 0.88 (0.48-1.60)
Sales 1.18 (0.96-1.45) 1.19 (0.97-1.46)
Agricultural self-employed 1.22 (0.98-1.52) 1.23 (0.98-1.54)
Services 1.08 (0.83-1.39) 1.07 (0.83-1.38)
Skilled manual 0.92 (0.68-1.24) 0.93 (0.69-1.26)
Unskilled manual 1.14 (0.63-2.07) 1.10 (0.61-1.98)
Husband occupation
Not working (ref)
Professional or technical or managerial 0.74 (0.42-1.29) 0.80 (0.45-1.39)
Clerical 0.73 (0.38-1.39) 0.79 (0.42-1.49)
Sales 0.69 (0.42-1.13) 0.74 (0.46-1.21)
Agricultural self-employed 0.82 (0.50-1.35) 0.91 (0.56-1.48)
Service 0.68 (0.41-1.14) 0.75 (0.45-1.25)
Skilled manual 0.91 (0.56-1.48) 0.97 (0.60-1.56)
Unskilled manual 0.52 (0.29-0.95)∗ 0.58 (0.32-1.04)
Religion
Catholic (ref)
Protestant 1.04 (0.87-1.24) 1.00 (0.83-1.19)
Other Christians 0.90 (0.69-1.18) 0.86 (0.66-1.12)
Muslim 0.88 (0.70-1.10) 0.96 (0.76-1.21)
Other 0.61 (0.38-0.98)∗ 0.67 (0.42-1.06)
Media exposure
No (ref)
Yes 1.12 (0.92-1.36) 1.08 (0.89-1.31)
Economic status
Quintiles 1 (ref)
Quintiles 2 1.51 (1.16-1.98)∗∗ 1.32 (1.00-1.74)∗
Quintiles 3 1.59 (1.18-2.13)∗∗ 1.39 (1.01-1.90)∗
Quintiles 4 1.93 (1.39-2.69)∗∗∗ 1.69 (1.17-2.44)∗∗
Quintiles 5 2.19 (1.51-3.16)∗∗∗ 1.90 (1.25-2.88)∗∗
Decision-making
No (ref)
Yes 1.04 (0.89-1.20) 0.98 (0.85-1.14)
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negative consequences for perinatal and neonatal as well as
maternal health [42]. Evidence shows that complicated and
worse outcomes of pregnancy among disadvantaged women
such as poorest/poor, uneducated, and rural residents are
very common in low- and middle-income countries [59].
Hence, supporting women in such locations is required to
lessen their suffering from the problem and poverty as well
as to achieve equitable health service [57].
Table 2: Continued.
Variables Model 0 Model I AOR [95% CI] Model II AOR [95% CI] Model III AOR [95% CI]
Skill ANC
No (ref)
Yes 18.25 (10.88-30.62)∗∗∗ 18.54 (11.05-31.10)∗∗∗
Sex of HH head
Male (ref)
Female 1.07 (0.88-1.30) 1.03 (0.85-1.26)
Distance to HF
Big problem (ref)
Not a big problem 1.28 (1.11-1.48)∗∗ 1.19 (1.02-1.39)∗
Place of residence
Urban (ref)
Rural 0.89 (0.70-1.15) 1.08 (0.83-1.41)
Region
Adamawa (ref)
Centre (without Yaoun) 1.44 (0.89-2.35) 0.98 (0.59-1.63)
Douala 1.38 (0.82-2.31) 0.91 (0.54-1.55)
East 1.76 (1.14-2.71)∗ 1.34 (0.85-2.13)
Far-North 1.05 (0.71-1.56) 0.92 (0.61-1.39)
Littoral (without Dou) 1.17 (0.70-1.95) 0.72 (0.43-1.22)
North 0.32 (0.20-0.50)∗∗∗ 0.27 (0.17-0.43)∗∗∗
North-West 2.40 (1.49-3.86)∗∗∗ 1.44 (0.88-2.36)
West 1.27 (0.78-2.06) 0.77 (0.47-1.27)
South 3.08 (1.89-5.02)∗∗∗ 2.09 (1.27-3.45)∗∗
South-West 1.53 (0.78-3.03) 1.04 (0.52-2.07)
Yaounde 1.23 (0.74-2.05) 0.87 (0.52-1.47)
Community literacy level
Low (ref)
Medium 1.22 (0.89-1.67) 0.98 (0.71-1.34)
High 1.36 (0.95-1.96) 1.10 (0.76-1.59)
Community socioeconomic status
Low (ref)
Moderate 1.21 (0.93-1.56) 1.08 (0.83-1.40)
High 1.21 (0.88-1.67) 1.05 (0.75-1.47)
Random effect result
PSU variance (95% CI) 0.77 (0.60-0.98) 0.45 (0.33-0.61) 0.31 (0.21-0.44) 0.26 (0.18-0.40)
ICC 0.19 0.12 0.08 0.07
LR test 308.19 121.02 71.58 52.73
Wald chi-square and p-value Reference χ2 = 230:37, P < 0:001 χ2 = 215:02, P < 0:001 χ2 = 332:48, P < 0:001
Model fitness
Log-likelihood -2988.28 -2775.28 -2891.00 -2723.31
AIC 5980.56 5616.57 5820.01 5546.63
PSU 427 427 427 427
N 5,013 5,013 5,013 5,013
Notes: ∗ significant at P < 0:05, ∗∗ significant at P < 0:01, ∗∗∗ significant at P < 0:001; ref: reference; AIC: Akaike Information Criterion.
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Skilled ANC was found to have a positive influence on
the uptake of deworming medication. The odds of taking
deworming medication among pregnant married women
who had skilled ANC were higher compared to pregnant
married women who had no skilled ANC. The evident justi-
fication for a higher uptake of deworming medication among
pregnant married women with skilled ANC could be due to
the fact that WHO recommended to routinely provide this
medication for all women after the first trimester especially
among the community with a high prevalence of STH and
anemia among women for positive pregnancy outcome
[42]. Therefore, the higher association between skilled ANC
and uptake of deworming medication indicating that
strengthening ANC service could substantially increase the
coverage of deworming medication in the country [43].
This study shows that the likelihood of taking deworm-
ing medication among pregnant married women who
reported distance to a health facility is not a big problem
was higher compared to pregnant married women who
reported the distance to a health facility is a big problem.
In Cameroon, distances to health facilities are big problems
for about 40% of the women [38]. According to 2018 CDHS,
72% of women aged 15-49 encountered problems in acces-
sing health care services for at least one of the four reasons:
getting permission, money, going alone, or distance to a
health facility [38]. Scholars have documented that low eco-
nomic and physical distance to health facilities, where poor
individual mostly living farther from the health facility than
the rich individual [60, 61]. The capacities to afford health
service significantly affect the utilization of health service
[62]. Hence, even if the health service is required for them,
because of the influence of long distance to health facilities,
poor uptake of maternal and child health services is seen
in many studies [37, 63, 64].
We found significant variation in the odds of having
deworming medication among pregnant married women
across regions where they lived. More specifically, compared
to pregnant married women living in the Adamawa region,
we found that the likelihood of taking deworming medica-
tion among pregnant married women who were living in
the South region was higher, while lower odds are reported
among women in the North region. Evidence in Cameroon
shows that maternal and child health services are varied
across regions, where many of the maternal services includ-
ing ANC and skilled delivery services remains very low, and
high child mortality is observed [65]. For instance, according
to the 2014 Cameroon MICS report, under-five mortality in
the North region was 173 per 1000 live birth, which was
higher as compared to the national average of 103 deaths
per 100 live births and 52 deaths per 100 live births in both
Yaounde and Douala regions [65, 66]. Similarly, based on
the skilled delivery attendance in the North region was 35%
while 99% in the Douala region [65].
4.1. Strengths and Limitations of Study. The major strength of
our study lies in the use of data from the most recent nation-
ally representative demographic and health survey. Again,
producing up-to-date evidence about coverage and indivi-
dual/household and community level predictors could reveal
the country’s gaps from the ideal target and recognizing the
current predictors. Findings from our study can help to eval-
uate and revise plans regarding the provision of deworming
medication among pregnant married women in Cameroon.
The robust nature of methodology used in DHS such as mul-
tistage sampling with a high response rate can increase the
generalizability of results to all pregnant women in
Cameroon. Using advanced statistical models that consider
individual/household and community level predictors also
increase the quality of the paper. However, the study has
the following limitations. First, variables not found in the
dataset such as drug supply and other variables like percep-
tion and attitude were not covered. Second, the cross-
sectional nature of the data does not allow for a cause-effect
relationship. Finally, since the data are self-reported, the
finding might be affected by recall bias.
5. Conclusions
The findings show women’s educational level, household
economic status, and skilled ANC are significant individual/-
household level predictors, whereas the distance to health
facility and region was the community-level predictors of
deworming medication utilization in Cameroon. Therefore,
women empowerment through education and economy as
well as improving the economic capacity of poor households
could help in enhancing uptake of deworming medication.
Moreover, giving attention to pregnant women living in far
distances from health facilities and the north region residents
can help in achieving equity-based maternal health service
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